Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lipitor, Lovastatin Are “Best Buy” Statins, Consumers Union Says

This article was originally published in The Pink Sheet Daily

Executive Summary

Pfizer’s statin is rated the best value for patients needing to reduce LDL cholesterol more than 40%, but generic lovastatin is best for patients needing a smaller reduction. Consumer Reports publisher posts drug comparison reports for statins, NSAIDs and PPIs on its website.

You may also be interested in...



"Best Buy" NSAID Rxs Up Since Vioxx Withdrawal, But Mobic Growing Faster, Consumers Union Says

Prescriptions for Abbott/Boehringer Ingelheim's Mobic doubled from September to March and the average retail price rose 9% in the same period, Consumers Union notes. Scripts for ibuprofen were up 28%, but prices were "relatively flat," the report says.

"Best Buy" NSAID Rxs Up Since Vioxx Withdrawal, But Mobic Growing Faster, Consumers Union Says

Prescriptions for Abbott/Boehringer Ingelheim's Mobic doubled from September to March and the average retail price rose 9% in the same period, Consumers Union notes. Scripts for ibuprofen were up 28%, but prices were "relatively flat," the report says.

AARP Drug Website Includes Effectiveness, Safety And Cost Comparisons

New site lists median prices and typical price ranges for drugs in nine classes based on prices submitted by AARP Pharmacy Services network pharmacies. Information will eventually be expanded to cover 20 classes of drugs.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS058561

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel